Results 271 to 280 of about 964,099 (295)

Interpreting results from biomarker-guided clinical trials: avoiding "negative" or "failed" terminology. [PDF]

BMC Med
Noor NM, Zheng H, Robertson DS, Savage J, Yap C, Jorgensen AL, Wason JMS, MRC-NIHR Trial Methodology Research Partnership (TMRP) Precision Medicine Working Group.   +7 more
europepmc   +1 more source

Imaging of Lipid Droplets in Living Cells and Mice with Metabolic Dysfunction‐Associated Steatotic Liver Disease via a Galactose‐Modified Supramolecular Near‐Infrared Fluorescent Glycoprobe

Advanced Functional Materials, EarlyView.
A galactose‐modified supramolecular near‐infrared (NIR) glycoprobe, TCF‐FBN@Gal‐BSA, enables targeted delivery to the liver through the asialoglycoprotein receptor (ASGPR) and facilitates liver‐targeting fluorescence visualization of lipid droplets (LDs) in metabolic dysfunction‐associated steatotic liver disease (MASLD) mice.
Han‐Min Wang, Lei Dong, Qiu‐Lian Hao, Lu‐Lu Sun, Xin‐Rong Li, Yu‐Wei Yuan, Ming‐Ye Tang, Jin Gong, Yi Zang, Jia Li, Tony D. James, Xiao‐Peng He, Hai‐Hao Han   +12 more
wiley   +1 more source

Optimization of oncology biomarker testing in managed care: Best practices and consensus recommendations from an AMCP Market Insights program. [PDF]

J Manag Care Spec Pharm
Brixner D, Richardson T, Lockhart CM, Ramsey S, Fox J, Pritchard D, Mcleod H, Bobolts L, Bourbeau B, Crum E.   +9 more
europepmc   +1 more source

Lebrikizumab Rapidly Lowers Inflammatory Biomarkers with Clinical Correlations in Moderate-to-Severe Atopic Dermatitis. [PDF]

Dermatol Ther (Heidelb)
Guttman-Yassky E, Sun Z, Mena LR, Hahn N, Nickoloff BJ, Preuss C, Siu K, Natalie CR, Gallo G, Wolf E, Eyerich K, Aparici M, Benschop RJ, Okragly A.   +13 more
europepmc   +1 more source

Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent. [PDF]

Alzheimers Dement
Nobili A, D'Amelio M.
europepmc   +1 more source

Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures. [PDF]

NPJ Precis Oncol
Liu T, Zhong L, Sun X, He Z, Lv W, Deng L, Chen Y.   +6 more
europepmc   +1 more source